BioSpace News Archive

Biotech Beach

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic.

May 9, 2024
·
5 min read
Business

Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.

May 9, 2024
·
17 min read
BioMidwest

Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension

Inhibikase Therapeutics, Inc. announced that the Company has received final meeting minutes from its recent pre-IND meeting with the Division of Cardiology and Nephrology of the U.S. Food and Drug Administration for IkT-001Pro as a candidate treatment for Pulmonary Arterial Hypertension.

May 9, 2024
·
5 min read
Drug Development

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

Rani Therapeutics Holdings, Inc. announced that it will present clinical and preclinical and data on the RaniPill® capsule, the company’s oral delivery platform, at Digestive Disease Week® taking place both virtually and in-person on May 18-21, 2024 in Washington, DC.

May 9, 2024
·
3 min read
Genetown

Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc., announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and one-on-one investor meetings at the 2024 RBC Capital Markets Global Healthcare Conference to be held May 14-15, 2024 in New York, NY.

May 9, 2024
·
3 min read
Business

CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates

CG Oncology, Inc., a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, reported financial results for the first quarter ended March 31, 2024, and provided business updates.

May 9, 2024
·
6 min read
BioMidwest

Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations

Kraig Biocraft Laboratories, Inc., announces that the spring production trials of the Company’s new BAM-1 hybrid parental strains have concluded, exceeding all expectations for scale, performance and robustness.

May 9, 2024
·
4 min read
Genetown

Fulcrum Therapeutics to Participate in Upcoming May Conferences

Fulcrum Therapeutics, Inc. today announced that management will participate in the following conferences: RBC Capital Market Global Healthcare Conference Wednesday May 15 at 4:05 p.m. ET.

May 9, 2024
·
1 min read
Pharm Country

Epitor Therapeutics Unveils CasNano: A Compact, All-in-One CRISPR/Cas for Single AAV Therapies at the American Society of Gene & Cell Therapy Annual Meeting

Epitor Therapeutics, a biotechnology pioneer in epigenetic editing, announces the creation of CasNano, a groundbreaking ultracompact Cas protein.

May 9, 2024
·
2 min read
Business

argenx Reports First Quarter 2024 Financial Results and Provides Business Update

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced its first quarter 2024 results and provided a business update.

May 9, 2024
·
14 min read